Research is casting prediction markets as policy-relevant forecasting tools just as state regulators escalate efforts to ...
— Initial Orders Received and Fulfilled from Multiple Transplant Centers, with YARTEMLEA Now Administered to Both Adult and Pediatric Patients with TA-TMA — YARTEMLEA is the first and only approved ...
New insights from Gordon Fraser spotlight a Triple Lipid Complex that supports skin barrier function, hydration, and ...
Omeros Corporation (NASDAQ: OMER) today announced that the first commercial shipments of YARTEMLEA ® (narsoplimab-wuug) to its distributors were completed last week, with orders from transplant ...
— Initial Orders Received and Fulfilled from Multiple Transplant Centers, with YARTEMLEA Now Administered to Both Adult and Pediatric Patients with TA-TMA — Omeros Corporation (NASDAQ: OMER) today ...
SEATTLE, January 27, 2026--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that the first commercial shipments of YARTEMLEA ® (narsoplimab-wuug) to its distributors were completed ...
Investing.com -- Omeros Corporation (NASDAQ:OMER) stock rose 3.1% on Tuesday after the company announced it has completed its first commercial shipments of YARTEMLEA (narsoplimab-wuug) to distributors ...
An evidence-informed, AI-enabled daily contemplative practice to help people actively shape their whole-person health ...
Type 2 diabetes and high blood pressure share a genetic link, new research from the University of Surrey, UK and the Université de Lille, France shows. People with one condition are more likely to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results